Results 1 to 10 of about 9,493 (159)

Complement C5 inhibition with eculizumab or ravulizumab is associated with increased cardiovascular and thromboembolic risk after ST-elevation myocardial infarction: a propensity-matched global retrospective cohort study. [PDF]

BMC Cardiovasc Disord
Vahldieck C.
europepmc   +1 more source

Comparative Efficacy of Complement Inhibitors in Complement Inhibitor-Naïve PNH: A Systematic Review With Supportive Exploratory Network Meta-Analysis of Randomized Trials. [PDF]

EJHaem
Ishaque R, Talpur AS, Sidra H, Memon H, Memon FT, Talat F, Rafiq T, Rayamajhi S.   +7 more
europepmc   +1 more source

Use of narsoplimab for eculizumab-refractory adult transplant-associated thrombotic microangiopathy (TA-TMA). [PDF]

Ann Hematol
Young S, Varadarajan I.
europepmc   +1 more source

Effectiveness and Safety of Eculizumab in Highly Active AChR+gMG and Its Therapeutic Response in Different Subtypes of gMG. [PDF]

Immunotargets Ther
Ma T, Liu Y, Zhu Y, Gao Y, Wang X, Liang Y, Wang B, Zhu R.   +7 more
europepmc   +1 more source

Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational study. [PDF]

Ann Hematol
Iori AP, De Vivo A, Di Bona E, Caocci G, Fioritoni F, Ciceri F, Beggiato E, Rapezzi D, Amendola A, Figuera A, Selleri C, Longu F, Fattizzo B, Tucci A, Cignetti A, Amico V, Sica S, Metafuni E, Raso S, Urbano TA, Marano L, Di Renzo N, Spedini P, Rambaldi A, Lanza F, Clissa C, Danesin C, Greve MB, Cabibbo S, Ori A, Cassanelli F, Sottana F, Campolo B, Gasparri G, Carini F, Barcellini W.   +35 more
europepmc   +1 more source

Efficacy and safety of vemircopan as monotherapy in patients with paroxysmal nocturnal hemoglobinuria. [PDF]

Blood Adv
Kulasekararaj A, Browett P, Risitano AM, Patriquin CJ, Yenerel MN, Marceau D, Sahin F, Algarra JL, Ogawa M, Yu J, Cross NB, Notaro R, Lee JW, Brodsky RA.   +13 more
europepmc   +1 more source

Thrombotic Microangiopathy And Hypertensive Emergency After Cocaine Use: A Case Report. [PDF]

J Brown Hosp Med
Moreno-Mirón JM, Alfonso JD, White T, Mehdi A, Auron M.   +4 more
europepmc   +1 more source

Indirect treatment comparison of iptacopan versus pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and residual anemia despite C5 inhibitor treatment. [PDF]

J Comp Eff Res
Kulasekararaj A, Scheinberg P, Balp MM, Somenzi O, Wiyani A, Snellman J, Walsh S, Pannagl K, Steenkamp J, de Latour RP.   +9 more
europepmc   +1 more source

Cost-effectiveness of lifelong eculizumab versus disease monitoring of aHUS. [PDF]

Nephrol Dial Transplant
Orozco-Leal G, Vale L, Oluboyede Y, Brocklebank V, Bryant A, Chadwick T, Dunn S, Johnson S, Kavanagh D, Kennedy C, Lecouturier J, Weetman C, Wong E, Woodward L, Sheerin NS.   +14 more
europepmc   +1 more source